PubMed=7690326; DOI=10.1002/eji.1830230929
Feltkamp M.C.W., Smits H.L., Vierboom M.P.M., Minnaar R.P., de Jongh B.M., Drijfhout J.W., ter Schegget J., Melief C.J.M., Kast W.M.
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
Eur. J. Immunol. 23:2242-2249(1993)

PubMed=21439369; DOI=10.1016/j.mcp.2011.03.003
Schmitt M., Pawlita M.
The HPV transcriptome in HPV16 positive cell lines.
Mol. Cell. Probes 25:108-113(2011)

PubMed=26900913; DOI=10.1371/journal.pone.0149748; PMCID=PMC4763794
Li L.-L., Wang H.-R., Zhou Z.-Y., Luo J., Wang X.-L., Xiao X.-Q., Zhou Y.-B., Zeng Y.
C3-Luc cells are an excellent model for evaluation of cellular immunity following HPV16L1 vaccination.
PLoS ONE 11:E0149748-E0149748(2016)